In vitro cytogenetic results supporting a DNA nonreactive mechanism for ochratoxin A, potentially relevant for its carcinogenicity

Chemical Research in Toxicology

Volumn 21, Issue 6, 2008, Pages 1235-1243

  Mosesso, Pasquale ^a   Cinelli, Serena ^b   Piñero, Joaquin ^c   Bellacima, Raffaela ^a   Pepe, Gaetano ^a  

^a UNIVERSITY OF TUSCIA   (Italy)

^b Research Toxicology Centre   (Italy)

^c UNIVERSITY OF SEVILLE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

OCHRATOXIN;

ANEUPLOIDY; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARCINOGENICITY; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL LINE; CELL METABOLISM; CHEMICAL CARCINOGENESIS; CHEMICAL LABELING; CHROMOSOME SEGREGATION; CONTROLLED STUDY; COVALENT BOND; CYTOGENETICS; DNA ADDUCT; DNA BINDING; GENETIC RISK; GENOTOXICITY; HUMAN; HUMAN CELL; LYMPHOCYTE; MALE; METAPHASE; MICRONUCLEUS; MITOSIS; NONHUMAN; NORMAL HUMAN; POLYPLOIDY; RAT; SISTER CHROMATID EXCHANGE; STRUCTURAL CHROMOSOME ABERRATION;

ANIMALS; CARCINOGENS; CELLS, CULTURED; CHROMOSOME ABERRATIONS; CRICETINAE; DNA; DNA DAMAGE; HUMANS; KIDNEY; LIVER; LYMPHOCYTES; MALE; OCHRATOXINS; RATS; RATS, SPRAGUE-DAWLEY;

RODENTIA;

EID: 47049113238     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx800029f     Document Type: Article

References (72)

1. Kuiper-Goodman, T., and Scott, P. M. (1989) Risk assessment of the mycotoxin ochratoxin A. Biomed. Environ. Sci. 2, 179-248.
2. NTP (National Toxicology Program) (1989) Toxicology and carcinogenesis studies of ochratoxin A (CAS no. 303-47-9) in F344/N rats (gavage studies). Natl. Toxicol. Program Tech. Rep. Ser. 358, 1-142.
3. Thuvander, A., Breitholtz-Emanuelsson, A., and Olsen, M. (1995) Effect of ochratoxin A on the mouse immune system after sub chronic exposure. Food Chem. Toxicol. 33, 1005-1011.
4. Thuvander, A., Breitholtz-Emanuelsson, A., Brabencova, D., and Gadhasson, I. (1996) Prenatal exposure of balb/c mice to ochratoxin A: Effects on the immune system in the offspring. Food Chem. Toxicol. 34, 547-554.
5. Thuvander, A., Funseth, E., Breitholtz-Emanuelsson, A., Hallen-Palminger, I., and Oskarsson, A. (1996) Effects of ochratoxin A on the rat immune system after perinatal exposure. Nat. Toxins 4, 141-147.
6. Bruinink, A., and Sidler, C. (1997) The neurotoxic effects of ochratoxin A are reduced by protein binding but are not affected by ± phenylalanine. Toxicol. Appl. Pharmacol. 146, 173-179.
7. Monnet-Tschudi, F., Sorg, O., Honegger, P., Zurich, M., Huggett, A. C., and Schilter, B. (1997) Effects of naturally occurring food mycotoxin ochratoxin A on brain cells in culture. NeuroToxicology 18, 831-840.
8. O'Brien, E., and Dietrich, D. R. (2005) Ochratoxin A: The continuing enigma. Crit. Rev. Toxicol. 35, 33-60.
9. Pfohl-Leszkowicz, A., Petkova-Bocharowa, T., Chemozemsky, I. N., and Castegnaro, M. (2002) Balkan endemic nephropathy and associated urinary tract tumors: a review on aetiological causes and the potential role of mycotoxins. Food Addit. Contam. 19, 282-302.
10. IARC (International Agency for Research on Cancer) (1993) Ochratoxin A. IARC Monogr. Eval. Carcinog. Risks Hum. 56, 489-521.
11. Gautier, J., Richoz, J., Welti, D. H., Markovic, J., Gremaud, E., Guengerich, F. P., and Turesky, R. J. (2001) Metabolism of ochratoxin A: Absence of formation of genotoxic derivatives by human and rat enzymes. Chem. Res. Toxicol. 14, 34-45.
12. Gross-Stein-Meyer, K., Weymann, J., Hege, H. G., and Metzler, M. (2002) Metabolism and lack of DNA reactivity of the mycotoxin ochratoxin A in cultured rat and human primary hepatocytes. J. Agric. Food Chem. 50, 938-945.
13. Mally, A., Zepnick, H., Wanek, P., Eder, E., Dingley, K., Ihmels, H., Volkel, W., and Dekant, W. (2004) Ochratoxin A: Lack of formation of covalent DNA adducts. Chem. Res. Toxicol. 17, 234-242.
14. Mally, A., and Dekant, W. (2005) DNA adduct formation by ochratoxin A: Review of the available evidence. Food Addit. Contam. Suppl. 1, 65-74.
15. Grosse, Y., Baudrimont, I., Castegnaro, M., Betbeder, A. M., Creppy, E. E., Dirheimer, G., and Pfohl-Leszkowicz, A. (1995) Formation of ochratoxin A metabolites and DNA adducts in monkey kidney cells. Chem.-Biol. Interact. 95, 175-187.
16. Dai, J., Park, G., Perry, J. L., Ilichev, Y. V., Bow, D. A. J., Pritchrad, J. B., Faucet, V., Pfohl-Leszkowicz, A., Manderville, R. A., and Simon, J. D. (2004) Molecular aspects of the transport and toxicity of ochratoxin A. Acc. Chem. Res. 37, 874-881.
17. Pfohl-Leszkowicz, A., and Castegnaro, M. (2005) Further arguments in favour of direct covalent binding of ochratoxin A (OTA) after metabolic biotransformation. Food Addit. Contam. Suppl. 1, 1-13.
18. Wehner, F. E., Thiel, P. G., van Rensburg, S. J., and Demasius, I. P. (1978) Mutagenicity to Salmonella thyphimurium of some Aspergillus and Penicillium mycotoxins. Mutat. Res. 58, 193-203.
19. Bendele, A. M., Carlton, W. W., Krogh, P., and Lillehoj, E. B. (1985) Ochratoxin A carcinogenesis in the (C57BL/6J x C3H) mouse. J. Natl. Cancer Inst. 75, 733-742.
20. Wurgler, F. E., Friederich, U., and Schlatter, J. (1991) Lack of mutagenicity of ochratoxin A and B, citrinin, patulin and cnestine in Salmonella typhimurium TA102. Mutat. Res. 261, 209-216.
21. Zepnik, H., Pähler, A., Schauer, U., and Dekant, W. (2001) Ochratoxin A-induced tumor formation: is there a role of reactive ochratoxin A metabolites. Toxicol. Sci. 59, 59-67.
22. Föllmann, W., and Lucas, S. (2003) Effects of the mycotoxin ochratoxin A in a bacterial and a mammalian in vitro mutagenicity test system. Arch. Toxicol. 77, 298-304.
23. Obrecht-Pflumio, S., Chassat, T., Dirheimer, G., and Marzin, D. (1999) Genotoxicity of ochratoxin A by Salmonella mutagenicity test after bioactivation by mouse kidney microsomes. Mutat. Res. 446, 95-102.
24. Ehrlich, V., Darroudi, F., Uhl, M., Steinkellner, H., Gann, M., Majer, B. J., Eisenbauer, M., and Knasmüller, S. (2002) Genotoxic effects of ochratoxin A in human-derived hepatoma (HepG2) cells. Food Chem. Toxicol. 40, 1085-1090.
25. Auffray, Y., and Boutibonnes, P. (1986) Evaluation of the genotoxic activity of some mycotoxins using Escherichia coli in the SOS spot test. Mutat. Res. 171, 79-82.
26. Krivobok, S., Olivier, P., Marzin, D. R., Seigle-Murandi, F., and Steiman, R. (1987) Study of the genotoxic potential of 17 mycotoxins with the SOS Chromotest. Mutagenesis 2, 433-439.
27. Malaveille, C., Brun, G., and Bartsch, H. (1991) Genotoxicity of ochratoxin A and structurally related compounds in Escherichia coli strains: Studies on their mode of action. IARC Sci. Publ. 115, 261-266.
28. De Groene, E. M., Jahn, A., Horbach, G. J., and Fink-Gremmels, J. (1996) Mutagenicity and genotoxicity of the mycotoxin ochratoxin A. Environ. Toxicol. Pharmacol. 1, 21-26.
29. Zepnik, H., Völkel, W., and Dekant, W. (2003) Toxicokinetics of the mycotoxin ochratoxin A in F 344 rats after oral administration. Toxicol. Appl. Pharmacol. 192, 36-44.
30. Palma, N., Cinelli, S., Sapora, O., Wilson, S. H., and Dogliotti, E. (2007) Ochratoxin A-induced mutagenesis in mammalian cells is consistent with the production of oxidative stress. Chem. Res. Toxicol. 20, 1031-1037.
31. Mori, H., Kawai, K., Ohbayashi, F., Kuniyasu, T., Yamazaki, M., Hamasaki, T., and Williams, G. M. (1984) Genotoxicity of a variety of mycotoxins in the hepatocyte primary culture/DNA repair test using rat and mouse hepatocytes. Cancer Res. 44, 2918-2923.
32. Dörrenhaus, A., and Föllmann, W. (1997) Effects of Ochratoxin A on DNA repair in culture of rat hepatocytes and porcine urinary bladder epithelial cells. Arch. Toxicol. 71 709-713.
33. Dörrenhaus, A., Flieger, A., Golka, K., Schulze, H., Albrecht, M., Degen, G. H., and Föllmann, W. (2000) Induction of unscheduled DNA synthesis in primary human urothelial cells by the mycotoxin ochratoxin A. Toxicol. Sci. 53, 271-277.
34. Creppy, E. E., Kane, A., Dirheimer, G., and Lafarge-Frayssinet, C. (1985) Genotoxicity of ochratoxin A in mice: DNA single-strand break evaluation in spleen, liver and kidney. Toxicol. Lett. 28, 29-35.
35. Stětina, R., and Votava, M. (1986) Induction of DNA single-strand breaks and DNA synthesis inhibition by patulin, ochratoxin A, citrinin, and aflatoxin B1 in cell lines CHO and AWRF. Folia Biol. 32, 128-144.
36. Lebrun, S., and Föllmann, W. (2002) Detection of ochratoxin A-induced DNA damage in MDCK cells by alkaline single cell gel electrophoresis (comet assay). Arch. Toxicol. 75, 734-741.
37. Mally, A., Pepe, G., Ravoori, S., Fiore, M., Gupta, R. C., Dekant, W., and Mosesso, P. (2005) Ochratoxin a causes DNA damage and cytogenetic effects but no DNA adducts in rats. Chem. Res. Toxicol. 18, 1253-1261.
38. Savage, J. R. K. (1975) Classification and relationships of induced chromosomal structural changes. J. Med. Genet. 12, 103-122.
39. Kirsch-Volders, M., Sofuni, T., Aardema, M., Albertini, S., Eastmond, D., Fenech, M., Ishidate, M., Jr., Kirchner, S., Lorge, E., Morita, T., Norppa, H., Surrallés, J., Vanhauwaert, A., and Wakata, A. (2003) Report from the in vitro micronucleus assay working group. Mutat. Res. 540, 153-163.
40. Shelby, M. D. (1988) The genetic toxicity of human carcinogens and its implications. Mutat. Res. 204, 3-15.
41. Shackney, S. E., Smith, C. A., Miller, B. W., Burholt, D. R., Murtha, K., Giles, H. R., Ketterer, D. M., and Pollice, A. A. (1989) Model for the genetic evolution of human solid tumours. Cancer Res. 49, 3344-3354.
42. Bischoff, F. Z., Yim, S. O., Pathak, S., Grant, G., Siciliano, M. J., Giovanella, B. C., Strong, L. C., and Tainsky, M. A. (1990) Spontaneous abnormalities in normal fibroblasts from patients with Li-Fraumeni cancer syndrome: Aneuploidy and immortalization. Cancer Res. 50, 7979-7984.
43. Andreassen, P. R., Martineau, S. N., and Margolis, R. L. (1996) Chemical induction of mitotic checkpoint override in mammalian cells results in aneuploidy following a transient tetraploid state. Mutat. Res. 372, 181-194.
44. Rabinovitch, P. S., Reid, B. J., Haggitt, R. C., Norwood, T. H., and Rubin, C. E. (1989) Progression to cancer in Barrett's esophagus is associated with genomic instability. Lab. Invest. 60, 65-71.
45. Sandberg, A. A. (1977) Chromosome markers and progression in bladder cancer. Cancer Res. 37, 2950-2956.
46. Schutte, B., Reynders, M. M., Wiggers, T., Arends, J. W., Volovics, L., Bosman, F. T., and Blijham, G. H. (1987) Retrospective analysis of the prognostic significance of DNA content and proliferative activity in large bowel carcinoma. Cancer Res. 47, 5494-5496.
47. Stephenson, R. A., James, B. C., Gay, H., Fair, W. R., Jr., and Melamed, M. R. (1987) Flow cytometry of prostate cancer: Relationship of DNA content to survival. Cancer Res. 47, 2504-2507.
48. Giaretti, W. (1994) A model of DNA aneuploidization and evolution in colorectal cancer. Lab. Invest. 71, 904-910.
49. Brodsky, W. Y., and Uryvaeva, I. V. (1977) Cell polyploidy: its relation to tissue growth and function. Int. Rev. Cytol. 50, 275-332.
50. D'Amato, F. (1984) Role of polyploidy in reproductive organs and tissues. In Embriology of Angiosperms (Johri, B. M., Ed.) pp 523-566, Springer-Verlag, New York.
51. Kowles, R. V., and Phillips, R. L. (1988) Endosperm development in maize. Int. Rev. Cytol. 112, 97-136.
52. De Rocher, E. J., Harkins, K. R., Galbraith, D. W., and Bohnert, H. J. (1990) Developmentally regulated systemic endopolyploid in succulents with small genomes. Science 250, 4977-4999.
53. Usui, T., Yoshida, M., Abe, K., Osada, H., Isono, K., and Beppu, T. (1991) Uncoupled cell cycle without mitosis induced by a protein kinase inhibitor, K-252a. J. Cell Biol. 115, 1275-1282.
54. Yokoe, H., Masumi-Fukazawa, A., Sunohara, M., Tanzawa, H., Sato, K., Sato, T., and Fuse, A. (1997) Induction of polyploidization in the human erythroleukemia cell line (HEL) by protein kinase inhibitor (K252a) and the phorbol-ester TPA. Leuk. Lymphoma 25, 333-343.
55. 2/M arrest by the chemopreventive flavonoid apigenin. Mol. Carcinog. 33, 36-43.
56. Mantle, P. G., McHugh, K. M., Adatia, R., Gray, T., and Turner, D. R. (1991) Persistent karyomegaly caused by Penicillium nephrotoxins in the rat. Proc. Biol. Sci. 246, 251-259.
57. Boorman, G. A., McDonald, M. R., Imoto, S., and Persing, R. (1992) Renal lesions induced by ochratoxin A exposure in the F 344 rat. Toxicol. Pathol. 20, 236-245.
58. Maaroufi, K., Zakhama, A., Baudrimont, I., Achour, A., Abid, S., Ellouz, F., Dhouib, S., Creppy, E. E., and Bacha, H. (1999) Karyomegaly of tubular cells as early stage marker of the nephrotoxicity induced by ochratoxin A in rats. Hum. Exp. Toxicol. 18, 410-415.
59. Shackney, S. E., Smith, C. A., Miller, B. W., Burholt, D. R., Murtha, K., Giles, H. R., Ketterer, D. M., and Pollice, A. A. (1989) Model for the genetic evolution of human solid tumours. Cancer Res. 49, 3344-3354.
60. Reid, B. J., Haggit, R. C., Rubin, C. E., and Rabinovitch, P. S. (1987) Barrett's esophagus: Correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma. Gastroenterology 93, 1-11.
61. Rabinovitch, P. S., Reid, B. J., Haggit, R. C., and Norwood, T. H. (1989) Progression to cancer in Barrett's esophagus is associated with genomic instability. Lab. Invest. 60, 65-71.
62. Heselmeyer, K., Schrock, E., Du Manoir, S., Blegen, H., Shah, R., Steinbeck, G., Auer, G., and Reid, T. (1996) Gain of chromosome 3q defines the transition from cervical dysplasia to invasive carcinoma of the uterine cervix. Proc. Natl. Acad. Sci. U.S.A. 93, 479-484.
63. Ornitz, D. M., Hammer, R. E., Messing, A., Palmiter, R. D., and Brinster, R. L. (1987) Pancreatic neoplasia induced by SV40 T-antigen expression in acinar cells of transgenic mice. Science 238, 188-193.
64. Cross, S. M., Sanchez, C. A., Morgan, C. A., Schimke, S., Ramel, S., Idzerda, R. L., Raskind, W. H., and Reid, B. J. (1995) A p53-dependent mouse spindle checkpoint. Science 267, 1353-1356.
65. Nowell, P. C. (1976) The clonal evolution of tumor cell populations. Science 194, 23-28.
66. Brown, A. L., Odell, E. W., and Mantle, P. G. (2007) DNA ploidy distribution in renal tumours induced in male rats by dietary ochratoxin A. Exp. Toxicol. Pathol. 59, 85-95.
67. Rached, E., Pfeiffer, E., Dekant, W., and Mally, A. (2006) Ochratoxin A: Apoptosis and aberrant exit from mitosis due to perturbation of microtubule dynamics? Toxicol. Sci. 92, 78-86.
68. Mistry, P., Deacon, K., Mistry, S., Blank, J., and Patel, R. (2004) NF-kappaB promotes survival during mitotic cell cycle arrest. J. Biol. Chem. 9, 1482-1490.
69. Sauvant, C., Holzinger, H., and Gekle, M. (2005) Proximal tubular toxicity of ochratoxin A is amplified by simultaneous inhibition of the extracellular signal-regulated kinases 1/2. J. Pharmacol. Exp. Ther. 313, 234-241.
70. Stewart, Z. A., Leach, S. D., and Pietenpol, J. A. (1999) p21(Waf1/ Cip1) inhibition of cyclin E/Cdk2 activity prevents endoreduplication after mitotic spindle disruption. Mol. Cell. Biol. 19, 205-215.
71. Nasmyth, K. (2002) Segregating sister genomes: The molecular biology of chromosome separation. Science 297, 559-565.
72. Haering, C. H., and Nasmyth, K. (2003) Building and breaking bridges between sister chromatids. Bioessays 25, 1178-1191.